Most Cited & Viewed

Most Cited & Viewed Papers

Citations Article
 
Sickle Cell Disease, a Review
by Cameron K. Tebbi
 
Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania
by Manase Kilonzi, Hamu J. Mlyuka, Fatuma Felix Felician, Dorkasi L. Mwakawanga, Lulu Chirande, David T. Myemba, Godfrey Sambayi, Ritah F. Mutagonda, Wigilya P. Mikomangwa, Joyce Ndunguru, Agnes Jonathan, Paschal Ruggajo, Irene Kida Minja, Emmanuel Balandya, Julie Makani and Nathanael Sirili
 
Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy
by Sigbjørn Berentsen, Shirley D’Sa, Ulla Randen, Agnieszka Małecka and Josephine M. I. Vos
 
Burkitt Lymphoma Incidence in Five Continents
by Sam M. Mbulaiteye and Susan S. Devesa
 
Primary Cutaneous B-Cell Lymphoma: An Update on Pathologic and Molecular Features
by Marco Lucioni, Sara Fraticelli, Giuseppe Neri, Monica Feltri, Giuseppina Ferrario, Roberta Riboni and Marco Paulli
 
Molecular Pathogenesis of Follicular Lymphoma: From Genetics to Clinical Practice
by Cristina López, Pablo Mozas, Armando López-Guillermo and Sílvia Beà
 
Mechanisms of Organ Damage and Novel Treatment Targets in AL Amyloidosis
by Francesca Lavatelli
 
KSHV/HHV8-Associated Lymphoproliferative Disorders: Lessons Learnt from People Living with HIV
by Mark Bower and Antonino Carbone
 
Bing–Neel Syndrome: Update on Diagnosis and Treatment
by Evangeline Y. Wong, Shirley D’Sa, Monique C. Minnema, Jorge J. Castillo and Dipti Talaulikar
 
Future Developments in the Treatment of AL Amyloidosis
by Foteini Theodorakakou, Despina Fotiou, Meletios A. Dimopoulos and Efstathios Kastritis
Views Article
Sickle Cell Disease, a Review
by Cameron K. Tebbi
What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
by Marco Pizzi, Carmela Gurrieri and Attilio Orazi
Peripheral T-Cell Lymphomas of the T Follicular Helper Type: Clinical, Pathological, and Genetic Attributes
by Karthik A. Ganapathi, Kristin H. Karner and Madhu P. Menon
Cold Agglutinin Disease: A Distinct Clonal B-Cell Lymphoproliferative Disorder of the Bone Marrow
by Fina Climent, Joan Cid and Anna Sureda
Bing–Neel Syndrome: Update on Diagnosis and Treatment
by Evangeline Y. Wong, Shirley D’Sa, Monique C. Minnema, Jorge J. Castillo and Dipti Talaulikar
Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy
by Sigbjørn Berentsen, Shirley D’Sa, Ulla Randen, Agnieszka Małecka and Josephine M. I. Vos
Future Developments in the Treatment of AL Amyloidosis
by Foteini Theodorakakou, Despina Fotiou, Meletios A. Dimopoulos and Efstathios Kastritis
Burkitt Lymphoma Incidence in Five Continents
by Sam M. Mbulaiteye and Susan S. Devesa
Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies
by Johannes P. M. van de Mortel, Shirley D’Sa, Alexander F. J. E. Vrancken, Nicolette C. Notermans, Josephine M. I. Vos and Monique C. Minnema
TP53 Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective
by Federico Zingarelli, Letizia Zannoni and Antonio Curti
Downloads Article
Sickle Cell Disease, a Review
by Cameron K. Tebbi
What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
by Marco Pizzi, Carmela Gurrieri and Attilio Orazi
Treatment of Lower Risk Myelodysplastic Syndromes
by Valeria Santini
Future Developments in the Treatment of AL Amyloidosis
by Foteini Theodorakakou, Despina Fotiou, Meletios A. Dimopoulos and Efstathios Kastritis
Measurable Residual Disease Assessment in Multiple Myeloma: How Deep Is Enough?
by Joana Caetano, Filipa Barahona, Paulo Lúcio and Cristina João
Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies
by Johannes P. M. van de Mortel, Shirley D’Sa, Alexander F. J. E. Vrancken, Nicolette C. Notermans, Josephine M. I. Vos and Monique C. Minnema
Burkitt Lymphoma Incidence in Five Continents
by Sam M. Mbulaiteye and Susan S. Devesa
Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy
by Sigbjørn Berentsen, Shirley D’Sa, Ulla Randen, Agnieszka Małecka and Josephine M. I. Vos
Evolution in the Definition of Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: A Model for the Future of Personalized Medicine
by Elaine S. Jaffe and Antonino Carbone
Hematological and Biochemical Reference Ranges for the Population with Sickle Cell Disease at Steady State in Tanzania
by Anna Daniel Fome, Raphael Z. Sangeda, Emmanuel Balandya, Josephine Mgaya, Deogratius Soka, Furahini Tluway, Upendo Masamu, Siana Nkya, Julie Makani and Bruno P. Mmbando
Back to TopTop